NRXP NRx Pharmaceuticals, Inc.
NRx Pharmaceuticals, Inc. (NRXP) is confirmed to report earnings on November 17, 2026, before the market open. The consensus earnings estimate is a loss of $0.34 per share.
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About NRx Pharmaceuticals, Inc.
NRX Pharmaceuticals Inc. is a patient-focused, clinical stage pharmaceutical company. It creates therapies to treat diseases where no medicines currently exist. NRX Pharmaceuticals Inc., formerly known as Big Rock Partners Acquisition Corp., is based in RADNOR, Pa.
Sector
Healthcare
Industry
Drug Manufacturers/Other
Charts powered in part by Lightweight Charts™ by TradingView.